PHILADELPHIA–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/BIO2019?src=hash” target=”_blank”gt;#BIO2019lt;/agt;–The 2019 BIO International Convention runs June 3 – 6, 2019 at the
Pennsylvania Convention Center in Philadelphia, PA.
Business Wire is the official
news distribution partner for BIO 2019. Exhibitor profiles from
the convention are listed below.
Acumen Analytics is an information management and analytics
AlloMek strives to develop innovative therapeutics to patients with
rare and debilitating diseases. Targeting orphan diseases using
AlloMek was formed to develop, and out-license, a novel class of MEK
inhibitors represented by the lead compound CIP-137401.
CIP-1374 was discovered by Cheminpharma, LLC team. All intellectual
property and rights related to CIP-1374 were transferred from
Cheminpharma to AlloMek Therapeutics.
|Company:||Amarex Clinical Research|
Amarex is a CRO headquartered in Maryland (USA) providing complete,
worldwide clinical product safety & efficacy testing and FDA
regulatory services. Amarex helps companies from the pre-clinical
stage through the marketing approval application. Our custom
regulatory approval plan serves to guide efficient pre-clinical and
clinical testing and is helpful for fund raising.
If your management is new to the regulatory approval process, Amarex
can guide you through to success, serving as your virtual Clinical,
Medical Safety, Biometrics, and Regulatory departments to create and
execute the regulatory approval plan.
|Company:||American Gene Technologies|
AGT is a gene and cell therapy company with a gene-delivery platform
designed to rapidly develop cures to infectious diseases, cancers,
and monogenic disorders. AGT’s mission is to transform people’s
lives through genetic medicines that rid the body of disease. AGT’s
lead candidate for an HIV cure is expected to enter the clinic in
2019. In parallel, AGT has a patented immuno-oncology approach to
stimulate the body’s immune system to destroy solid tumors. AGT has
also developed a synthetic gene it expects to cure Phenylketonuria
(PKU) which is anticipated to reach the clinic in 2020.
|Company:||American Laboratory Trading|
American Laboratory Trading, a BIO Business Solutions® provider and
Agilent Channel Partner, specializes in Asset Recovery, Refurbish
and Resale services of secondary lab equipment in the life sciences
Our asset recovery program goes beyond a ‘one-size-fits-all’
approach. Whether you need to monetize one instrument, liquidate an
entire lab or require ongoing program management, we can help.
Our refurbish and resale services offer our customers a lower point
of entry to high-quality, brand name instrumentation. We carry more
than 12,000 instruments in-stock, ranging from benchtop accessories
to triple quad mass spectrometers.
|Learn more at www.ALT.bio.|
Ardigen is a life science computational partner in the era of
Artificial Intelligence. We provide comprehensive technology and
custom services that leverage our domain knowledge and expertise in
bioinformatics, machine learning and software engineering together
with our proprietary technology. Ardigen platforms for neoepitope,
biomarker, and microbiome research facilitate the improvement of the
response rates in immuno-oncology.
|Company:||Asta Pharmaceuticals Co., Ltd.|
We are a privately held company based in Toyama, Japan with
|Company:||Avacta Life Sciences|
|Ticker Symbol & Exchange:||AVCT:LON|
At Avacta Life Sciences, our mission is to create a high quality,
powerful set of tools to help Life Scientists accelerate the
understanding of biology and disease and to help them apply these
advances to diagnosis and treatment. Affimer® reagents are
engineered affinity proteins that are set to revolutionise the
reagents market. They are based on a small protein scaffold that can
be engineered to bind with high specificity and affinity to a wide
range of protein targets. With a ground-breaking rapid custom
service and a growing online catalogue, Affimer reagents can be used
for a wide range of applications in diagnostics, drug/biomarker
discovery, biotech research & development and as therapeutic agents.
|Company:||Axiom Real-Time Metrics|
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful
and cost-effective eClinical solutions and services focused around
small to medium biotech, medical device and CROs. Services include:
Data Management, Data Analytics, Biostatistics and
Pharmacovigilance. Axiom’s eClinical suite, Fusion, delivers a
powerful range of innovative end-user focused, unified functionality
and 15 modules. Axiom serves as the Connected Hub for your entire
clinical study data and operational needs. Fusion Delivers: EDC, DM,
IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE
Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7
Project and Clinical Data Reporting.
|For more information, please visit http://www.axiommetrics.com/.|
|Company:||BIO Asia-Taiwan 2019 (Taiwan BIO)|
Co-organized by the global Biotechnology Innovation Organization
(BIO) and the Taiwan Bio Industry Organization (Taiwan BIO), the
inaugural BIO Asia-Taiwan 2019 Conference and Exhibition will be
held in Taipei, Taiwan 24-28 July, 2019. A week-long festival of
biotech-themed conferences, meetings, and presentations, BIO
Asia-Taiwan is poised to become Asia’s most important gathering of
the biotechnology community. Join 1,500 participants from 25
countries at the 3-day conference for sessions on AI for healthcare,
advances in precision medicine, cell and gene therapies, M&A in the
healthcare sector, and more. Participate in BIO One-on-One
Partnering, and take in the latest products and technologies from
more than 600 companies at the four-day exhibition.
BioCT is dedicated to growing the vibrant bioscience ecosystem in
Connecticut by supporting innovation, collaboration, networking,
education, talent engagement and advocacy. We bring together
companies, institutions, entrepreneurs, investors, government,
service providers, and other passionate, dedicated people, to create
a thriving community to improve patients’ lives and public health
and drive economic growth.
A global leader in providing risk reduction solutions, Bioquell’s
wide range of bio-decontamination systems and services help
facilities establish a safe and productive working environment. With
Bioquell’s proprietary and EPA registered 35% Hydrogen Peroxide
Vapor technology, you can eliminate bioburden within lab spaces and
rooms, manufacturing areas, equipment, pass-throughs, and more.
Backed by numerous peer-reviewed studies and trusted around the
world, the process is rapid, effective, and residue-free. Bioquell’s
technology distributes Hydrogen Peroxide Vapor on all exposed
surfaces, providing a 6-log kill. We also offer uniquely designed,
modular isolators integrated with Bioquell bio-decontamination
technology. Visit www.bioquell.com for more information.
|Ticker Symbol & Exchange:||NYSE:BIO|
Bio-Rad is a global leader in developing, manufacturing, and
marketing a broad range of innovative products for the life science
research and clinical diagnostic markets. With a focus on quality
and customer service for over 65 years, our products advance the
discovery process and improve healthcare. Our customers include
university and research institutions, hospitals, biotech and pharma.
Bio-Rad is among the top five life science companies in the world,
providing instruments, software, consumables, reagents, and content
for the areas of cell biology, gene expression, protein
purification, protein quantitation, drug discovery and manufacture,
food safety, and science education.
BioTalent Canada is the HR partner of and a catalyst for growth in
Canada’s bio-economy. Our engagement with employers, associations,
post-secondary institutions, immigrant serving agencies and service
providers has built a dynamic network that is strengthening skills,
connecting job-ready talent to industry and creating opportunities.
Please visit biotalent.ca for more information.
|Company:||Biotech Primer Inc.|
Biotech Primer develops and delivers customized training on the
science and regulatory processes driving the biotechnology,
pharmaceutical, and medical device industries. With continuously
updated materials and industry expert instructors, Biotech Primer
provides the most relevant life science courses worldwide.
|Company:||BRG Regulatory Consulting|
BRG Regulatory Consulting is a full service regulatory and product
development consulting firm. BRG has an excellent reputation as a
leading NDA, 510k, and IND consulting firm, which has clients and
consultants in over 60 countries across the globe. The primary aim
of BRG is to provide efficient and expeditious services and give the
best solutions for our clients’ products that include drugs, medical
devices, biologics, cosmetics, cGMP, quality assurance, and
scientific services. BRG has the expertise you need to increase your
chances of initial FDA approval, saving you both time and resources.
|Company:||Cayman Chemical Company|
Cayman provides pre-clinical discovery and development services to
the global pharmaceutical, biotechnology, and academic research
markets. Our diverse suite of services leverages a team of over 150
highly skilled scientists with expertise in medicinal chemistry,
structure-based drug design, complex multi-step organic synthesis,
analytical chemistry, sample analysis and custom assay development.
We offer a personalized, flexible approach that enables our clients
to accelerate their drug discovery and development through a
single-source partner, from novel drug design and synthesis to
target identification and validation. Visit us at BIO 2019 Exhibitor
|Company:||Celeritas Solutions, LLC|
Celeritas Solutions is a clinical financial management company
|Company:||Cell Microsystems, Inc.|
Cell Microsystems develops, manufactures, and markets innovative
products for single cell research that provide flexibility in
imaging, sorting, and isolation. The CellRaft AIR System and
CytoSort Array enables high-efficiency sorting and isolation of
single cells under standard culture conditions resulting in
unperturbed phenotypes and high viability. A user can select a cell
in real-time and ‘track and trace’ that cell through imaging,
collection and downstream analysis, even for small, precious
samples. The AIR System is uniquely applicable to a broad range of
applications including genomics, cancer research, T-cell screening
in search of immunotherapies, CRISPR gene editing, and stem cell
Clinlogix is a Global Clinical Research Organization working to
improve human quality of life by supporting and accelerating
innovation in the life science industry. Its full suite of clinical
research services supports the regulatory and clinical development
pathway of medical devices, pharmaceuticals, biologics and
diagnostics from proof of concept/discovery, early
feasibility/first-in-human, through pivotal and the
post-marketing/safety surveillance of client products. The company
delivers this global expertise by way of its regional office
locations in the US – Lower Gwynedd, Pennsylvania, Europe – Mainz,
Germany, South America – Medellin, Colombia and Asia – Tokyo, Japan.
Clinvet + Hodei Tech
It is only in the last few years that the Animal Health sector has
We invite you to stop by Booth 4262 (opposite the
CI is Connecticut’s strategic venture capital arm and is the leading
source of financing and ongoing support for innovative, growing
companies. By offering equity investments, strategic guidance and
introductions to valuable partners, we enable promising businesses
|How we help:|
•Investment: Venture capital and strategic support for early-stage
•Connections: Introductions to our vast network of small and big
businesses, talent, university researchers, service providers,
suppliers and more.
•Business Advisers: Mentors who specialize in your sector or the
skills you need, including executives in residence.
CoreRx, a Contract Development Manufacturing Organization (CDMO)
with capabilities to support clinical – niche commercial
manufacturing, offering state of the art facilities to support your
supply chain needs. Our integrated offerings provide comprehensive
services for the development, manufacturing, and testing of solid,
liquid and semi-solid dosage forms.
|Company:||Crowell & Moring LLP|
Crowell & Moring LLP is an international law firm with approximately
550 lawyers representing clients in litigation and arbitration,
regulatory, and transactional matters. Our experienced life sciences
team helps businesses and individuals explore and exploit new
opportunities and markets for their products and ideas, ensure
compliance with regulatory requirements, and resolve disputes
through litigation, mediation, and settlement. Our clients include
individual inventors, research labs, privately owned start-ups,
small to large biotech product and platform companies, and
multinational pharmaceutical, and bioagricultural companies. The
firm has offices in Washington, D.C., New York, Los Angeles, San
Francisco, Orange County, London, and Brussels.
Daicel Corporation, a leader in analysis, manufacturing, and
celebrating 100 years of service to the scientific community, is
expanding its Life Science portfolio to meet the challenges of a
rapidly evolving pharmaceutical industry. Daicel Pharma Services
offers innovative analytical solutions to support timely, safe drug
development with improved cost efficiency. Our GMP facilities are
FDA compliant and offer a full range of analytical method
development, validation, and transfer on formulation products and
drug substances. Daicel Pharma Standards offers a wide range of
high-quality pharmaceutical standards of >95%. Our experienced
chemists employ strict manufacturing protocols to produce effective,
high-purity and high-quality products.
DataArt is a global technology consultancy that designs, develops
and supports unique software solutions, helping clients take their
businesses forward. Recognized for their deep domain expertise and
superior technical talent, DataArt teams create new products and
modernize complex legacy systems that affect technology
transformation in select industries.
DataArt has earned the trust of some of the world’s leading brands
and most discerning clients, including Nasdaq, Travelport, Ocado,
Centrica/Hive, BetfairPaddyPower, IWG, Univision, Meetup and Apple
Leisure Group among others. DataArt brings together expertise of
over 2,800 professionals in 22 locations in the US, Europe, and
DeltaTrak®, Inc., is a leading innovator of food safety and cold
chain management and temperature monitoring solutions.
|Company:||DelveInsight Business Research|
DelveInsight is a Business Consulting and Market research company,
|Company:||Eurofins BioPharma Services|
|Ticker Symbol & Exchange:||ERFSF : Euronext 100|
Eurofins BioPharma Services is a full-service global organization
with dedicated testing facilities for Early Clinical Development,
Central Laboratory Services, Bioanalytical Services, Virology and
Immunology Testing Services, Anatomic Pathology and Genomics
Services. As a division of the Eurofins Scientific Group, our sole
and only focus is clinical laboratory analysis. With €3,781.1
million in annual revenues , over 45,000 employees in 800
laboratories across 47 countries, a portfolio of over 200,000
analytical methods and over 400,000,000 tests performed annually,
Eurofins Scientific is a world leader in laboratory science,
providing a unique range of analytical testing services to the
pharmaceutical, food, environment, and consumer product industries
and to governments.
|Company:||Fina Biosolutions LLC|
Fina Biosolutions LLC (Rockville, MD) is a conjugate vaccine
research and development company. Our mission is to promote
conjugate vaccines. We are a leading provider of conjugate vaccine
technology, including conjugation chemistry, laboratory services and
consulting. Chemistry developed by FinaBio scientists is used in
licensed vaccines world-wide. FinaBio is also a source for
affordable CRM197 vaccine carrier protein. We express CRM197 as a
soluble, properly-folded intracellular protein in E. coli, with high
expression levels and a simple purification process. The protein is
marketed as EcoCRM®. With EcoCRM® and our conjugate vaccine
expertise, we can help turn your antigens into vaccines.
|Company:||G-CON Manufacturing, Inc.|
G-CON Manufacturing designs, builds and installs prefabricated G-CON
POD® cleanrooms. G-CON’s POD portfolio provides cleanrooms in a
number of dimensions for a variety of uses, from laboratory
environments to personalized medicine and production process
platforms. G-CON POD® cleanroom units surpass traditional cleanroom
structures in scalability, mobility and the possibility of
repurposing the PODs once the production process reaches its
|Company:||GVK BIO | Aragen Bioscience|
Established in 2001, GVK BIO is a global Contract Research &
Hesperos Inc. provides insights into novel drug candidates at the
preclinical stage by evaluating their efficacy and safety using
sensitive, functional readouts in human-on-a-chip multi-organ models
to reduce and eventually eliminate use of animal models. This
innovative new technology is helping pharmaceutical researchers,
large and small, make more informed decisions on which drugs to move
forward with, ultimately bringing patients new therapeutics cheaper
and quicker than ever possible before and enabling patient specific
Telepresence: the next best thing to being there.
Hodei’s GEMINI and IKASI Telepresence programs simplify live
Trusted by scientists and medical professionals globally, Hodei
Schedule a meeting or stop by Booth 4262 (opposite the
The International Institute for the Advancement of Medicine (IIAM)
is at the forefront of providing non-transplantable, healthy and
diseased human organs and tissues to the medical research community.
Working with every organ procurement organization in the U.S., IIAM
receives over 15,000 organ referrals for research each year. We
assist with unprecedented collaborations by sourcing livers and
other organs for therapeutic applications and pre-clinical
investigations targeting a multitude of debilitating disorders.
IIAM’s breadth of services also includes a Neonatal Donor Program
that provides neonatal organs and tissues for medical research,
education and development. Please visit our website at www.iiam.org.
We are ILLUSTRATUM, a British biotechnology company who are
commercialising DARC Technology, developed by Professor M Francesca
Cordeiro through Wellcome Trust funding.
DARC technology is a new exploratory biomarker for use in glaucoma &
AMD clinical studies.
DARC combines an innovative patented biologic with a
state-of-the-art AI algorithm. For the first time in humans, using
standard imaging equipment, DARC is able to identify cellular level
DARC can de-risk clinical development, improving study outcomes
whilst reducing time to market and costs for glaucoma and AMD
InveniAI is a technology company that has pioneered the application
of artificial intelligence (AI) and machine learning (ML) to
transform innovation across healthcare and other industries.
Our flagship platform, AlphaMeld, was designed on the premise that
every innovation begins with a core discovery or invention that
Numerous industry collaborations with big pharma, specialty pharma,
biopharma, and consumer healthcare showcase the value of our
platform in recognizing complex patterns and associations that
represent the earliest signals of innovation.
JoVE is a productivity and training platform for pharmaceutical and
biotechnology companies creating innovative new medicines and cures.
With JoVE’s clearly visualized cutting-edge experiments with
peer-reviewed video articles, corporate scientists will:
|– Increase productivity in the lab,|
– Streamline training processes,
|– Learn emerging techniques and technologies,|
|– Skip avoidable experimental errors,|
|– Get results faster and beat R&D deadlines.|
Headquartered in Cambridge, Massachusetts, JoVE also maintains
offices in the United States, Europe, India, and Australia. Please
visit www.jove.com/biopharma to learn more.
Blood loss is the leading cause of preventable death after trauma.
KaloCyte, Inc., a preclinical biotech startup, has demonstrated
proof of concept for ErythroMer, a dried, bio-inspired artificial
red blood cell, to treat life-threatening hemorrhage when stored
blood is not an available option. This nano-encapsulated human
hemoglobin mimics RBC physiology and is a highly efficient oxygen
carrier. Its synthetic polymer shell makes it a universal option for
all blood types. It can be freeze-dried for long-term storage
without refrigeration, and quickly reconstituted for rapid
administration when needed – potentially saving thousands of lives
in pre-hospital settings.
ktMINE collects, organizes, and connects transactional and
Intellectual Property (patents, trademarks, agreements, royalty
rates, etc.) data to help you quickly and confidently perform
research. ktMINE then takes that data and turns it into real,
With ktMINE, quickly develop, value and create tactics to execute an
IP transaction strategy using a single tool. We support your IP
research, analysis and decision-making process with the ability to
investigate competitors, technologies, patents and other
intelligence to foster your IP transaction strategy, maximize your
IP asset strategy by leveraging data to drive commercialization &
monetization agreements and much more.
|Company:||Latham BioPharm Group|
Latham BioPharm Group provides the insight, knowledge, and network
to unite teams and technologies in the Life Sciences. We provide the
depth of expertise necessary to advance programs, by offering a
range of life science services including business development,
program management, functional subject matter expertise and
strategic consulting; with proven experience in biodefense/pandemic
response and strategic product development.
We assist clients in evaluating critical business decisions and
connecting with the target markets to assess opportunities. We
assist in finding and securing funding. We then drive successful
advancement to a targeted value-inflection point and help monetize
LAT Research is a privately-owned full-service CRO company which
operates in Latin American countries with staff dedicated to all
aspects of Regulatory Affairs, Strategic Planning, Clinical
Research, Medical Writing, Biostatistics and Pharmacovigilance. LAT
was created in 2010 to conduct the first full-scale clinical trial
in the setting of Chagas Disease in pediatric population. Since
then, our staff have been involved in 50 different studies, 26 of
them fully conducted enrolling more than 6,600 patients in different
therapeutic areas. Particularly in neglected diseases, LAT is the
more experienced organization in conducting clinical trials in
LATAM. Solid experience in helping companies to reach the goals for
priority review vouchers in neglected or tropical diseases, rare
disease or pediatric indications based on qualified staff and access
to target population.
|Ticker Symbol & Exchange:||ASX: LBT|
LBT Innovations is an Australian medical technology company using AI
to deliver automation in healthcare. The company has developed a
patent protected, machine learning and intelligent imaging platform
technology to deliver the only FDA Class II cleared instrument
utilizing AI technology in clinical microbiology.
The APAS® Independence automates the imaging, image analysis,
LBT Innovations is exploring opportunities to extend our platform
technology towards new healthcare applications requiring
cutting-edge computer vision and analysis.
Leuven MindGate represents the ecosystem of Leuven, a knowledge
region at the pinnacle of Health, High-Tech and Creativity, an ideal
place for companies and talented people.
LifeNet Health is a leading global provider of human transplant,
tissue allografts, and regenerative medicine solutions, driven by
our mission of saving lives, restoring health and giving hope. The
LifeSciences Division is dedicated to providing researchers with a
broad spectrum of services to drive human tissue and cell-based
discovery. Our resources and services include:
Human primary cells including hepatocytes and islets, biospecimens
for research, and a fully human 3D microtumor oncology assay system.
To learn more, contact us by email at
email@example.com or by phone at 757-464-4761.
|Company:||LMK Clinical Research Consulting|
Inspection Readiness. Two words that can ignite worry, fear, and
stress. At LMK, we work with our clients to alleviate those concerns
and ensure that you are inspection ready from Day One. We believe
that the clinical trial content is the foundation of every clinical
trial, and a strong foundation is key to the overall health and
stability of any clinical program. We offer our clients a
combination of expertise, tools, processes, and extensive knowledge
of the clinical drug development process. Our experts will assess
your study requirements and processes and create a plan customized
to meet your specific needs.
ManagedLab Services is a Certified Women Owned Small Business,
leading the life science industry in Lab Support, Vendor Managed
Inventory, and Project Management for U.S. based labs of all sizes,
from startup through large pharma.
We combine top-notch customer service with our expertise in best
practices for Laboratory Operations and overlay that with
cutting-edge automation to give you the most efficient lab available.
Our unique combination of highly trained PEOPLE, documented
PROCESSes, and reportable DATA ensures your lab is always
Our vendor agnostic approach allows us to support all products, from
all suppliers, giving you the FREEDOM OF CHOICE.
|Company:||Mazars USA LLP|
Mazars USA LLP is a high-performing accounting, tax and consulting
firm with significant national presence in strategic US geographies.
Since 1921, our dedicated professionals have leveraged technical
industry expertise to develop customized solutions for clients,
create value, and optimize their performance. We offer a broad array
of industry specialists providing services to growth-oriented
enterprises and individuals. As the independent US member firm of
Mazars Group, we deliver seamless access to the expertise of 23,000
professionals in 89 countries. At local and global levels, we are
proud of our value-added services, building lasting relationships
with our clients and communities. For more information, visit us at
|Company:||Meridian BioGroup LLC|
Meridian BioGroup is a Maryland-based service provider and
consultancy to FDA-regulated pharmaceutical and biopharmaceutical
companies, government institutes and academic institutions in the
areas of Quality, Validation and Regulatory Affairs. Established in
2007, Meridian currently employs 30 skilled professionals and eight
subcontracted partners, with a combined 400+ years of experience in
GXP (cGMP, GLP, GTP), CLIA and ISO and backgrounds in manufacturing,
quality control, quality assurance, regulatory affairs, engineering,
validation, and document control. We have experience in
pharmaceuticals, biologics, medical devices, biosimilars, and
combination products and extensive expertise with multi-product and
contract manufacturing facilities, contract testing operations, and
|Company:||National Taiwan Ocean University GLORIA|
The NTOU GLORIA serves as a platform further bridging the academia
and industry sectors through forming a strong alliance with
resources from both sectors and assets from NTOU’s resourceful
alumni and partner research institutes. The GLORIA provides
customized services to the industrial partners to meet their
specific needs to grow business. GLORIA focuses on advanced
aquaculture technology fields.
We build Industry-University-Institute platforms in order to link
Taiwan with the global market.
|We also provide industry consultant and scientific research services.|
Nuventra is a group of pharmaceutical scientists that partner as
virtual extensions of our clients’ teams. We focus on helping
companies avoid costly missteps in their development programs and
can increase their chances for regulatory authorization.
Specializing in nonclinical and clinical pharmacology,
pharmacokinetics, pharmacodynamics and modeling and simulation, our
consultants bring their 10-30 years of experience to advise on next
We can come on board as early as candidate selection and work
alongside through clinical studies. Our team can help identify risks
and the strategies to mitigate them.
We enable drug developers and investors to make better strategic
decisions. Our ability to translate complex PK/PD data into
actionable insights to inform development and investment decisions
is what makes us unique.
|Booth:||4270 – IZ-29|
Oligomerix is an early-stage biotechnology company focused on
discovering and developing novel, small-molecule tau oligomer
inhibitors for Alzheimer’s disease (AD) and related
neurodegenerative diseases with tau pathology. Oligomerix’ drug
discovery platform has identified a pipeline of novel, central
nervous system (CNS) small molecule lead compounds designed to
inhibit tau oligomer formation at the beginning of the aggregation
process. The company’s lead program targeting AD has initiated
IND-enabling studies. The NYC based company is located at the
Ullmann Research Center for Health Sciences within the Albert
Einstein College of Medicine and has received considerable support
from the National Institute of Health (NIH). Oligomerix is seeking
strategic partners to support the acceleration and advancement of
these important programs. For more information about Oligomerix,
please visit www.oligomerix.com.
|Company:||Ology Bioservices, Inc.|
Ology Bioservices is a biologics-focused Contract Development
Manufacturing Organization (CDMO) serving both government and
commercial clients from early stage through commercial product. The
company has 183,000 square feet of manufacturing, process
development, and quality assurance/quality control space in its
state-of-the-art facility in Alachua, FL; and an analytical,
bioanalytical, & cell-line development and testing laboratory in
Berkeley, CA. The experienced team at Ology Bio provides support in
upstream & downstream process development, formulation & analytical
development, and cGMP manufacturing of mAbs, recombinant proteins,
live viral products, nucleic acids, and cell & gene therapies up to
BioSafety Level 3 (BSL-3). The company also offers full regulatory
support from preclinical through licensure from its Frederick, MD
|Company:||Ompi – Stevanato Group|
Founded in 1949, Stevanato Group is committed to creating systems,
processes, and services that guarantee the integrity of parenteral
It comprises two operational divisions dedicated to serving the
pharmaceutical and healthcare industry: The Pharmaceutical Systems
Division, specialized in glass primary packaging, – through Ompi –
specialty plastics and delivery devices, and the Engineering Systems
Division dedicated to assembly and packaging solutions, as well as
reliable inspection systems. The Group also benefits from SG Lab
activity that provides technical and analytical services to ensure
drug’s integrity and device’s injection performance.
|Company:||Oxford Brain Diagnostics Ltd.|
Oxford Brain Diagnostics, a spinout from the University of Oxford,
has developed a novel approach (Cortical Disarray Measurement – CDM)
for extracting correlates of micro-anatomy from standard MRI brain
images, providing valuable information about Alzheimer’s disease
(paper under review). The past eight years has seen the
collaboration of two world class specialists – Dr Steven Chance
(CEO), Neuroscience and Pathology and Professor Mark Jenkinson
In unpublished tests, CDM has been used to classify which patients
will develop Alzheimer’s and other forms of dementia within 2 – 3
years. Early results indicate promising outcomes for differential
diagnosis between dementias.
|Company:||PARAS BIOPHARMACEUTICALS FINLAND OY|
Paras Biopharmaceuticals is a Finland-based Biopharmaceutical
company. We offer Microbial CDMO services, Biosimilars & Biologics,
and Bioprocess enzymes.
-Microbial CDMO for the production of Fusion Proteins scFv, Complex
Biologics, Nanobodies, Diabodies
-Biologics & Biosimilars – Recombinant Teriparatide, Recombinant
Anakinra (Kineret® Biosimilar), Recombinant Rasburicase and
Recombinant Romiplostim (N-plate® Biosimilar).
|-Bioprocess Enzymes – Recombinant TEV and Enterokinase.|
Paras Biopharmaceuticals has a fully equipped microbial production
facility in Finland, for the production of recombinant therapeutic
Please refer to our website www.parasbiopharma.com for further
PharmaEssentia Corp. is a fully integrated global biopharmaceutical
company headquartered in Taipei, Taiwan. It was established by a
group of highly accomplished scientists from leading pharmaceutical
companies, and led by seasoned executives with 100+ years of
experience at biotechnology and regulatory agencies. The company
aims to deliver efficacious, safe, and cost-effective therapeutic
products to treat human disease, while bringing long lasting value
Ropeginterferon alfa-2b is a novel, mono-pegylated proline
interferon alfa-2b invented by PharmaEssentia and manufactured at
its own biologics facility in Taichung, Taiwan. The biologics
facility had been certified by Taiwan Food and Drug Administration
and European Medicines Agency, and is also designed and operated to
be compliant with US FDA requirements.
|Company:||PMI BioPharma Solutions|
Located in Nashville, TN, PMI Bio provides high throughput library
screens and designs, develops and tests drugs in vitro and in vivo
using relevant cell lines and murine models. Our research scientist
also express and purify proteins and develop assays around protein
targets using NMR, SPR, crystallography, ITC, TR-FRET, and DSF to
name a few. We even have a vivarium with mice and rats bred
specifically for search supporting immunology, wound healing, cancer
research, genetics, diabetes and toxicology. PMI can also provide
you with aseptic and non-aseptic clinical trial materials.
|Ticker Symbol & Exchange:||QTRX NASDAQ|
Quanterix is a company that is digitizing biomarker analysis with
the goal of advancing the science of precision health and
dramatically changing the way healthcare is provided. Our two
ultra-sensitive technology platforms, Simoa® Bead and Simoa Planar
Array, give researchers the ability to quantify biomarkers for a
range of diseases at lower levels than ever before, in most common
sample types. Simoa’s ultra-sensitivity, multiplex detection
capability and flexibility in custom assay development are advancing
academic research and helping to accelerate drug development and
approval, both in our customers’ own facilities and by contract in
our CLIA-certified Quanterix Accelerator Laboratory.
|Company:||Queensland University of Technology|
Queensland University of Technology (QUT) is a major Australian
university internationally recognised as a provider of high-impact
medical and agricultural biotechnology research delivered through:
The Institute of Health and Biomedical Innovation (IHBI), a
multidisciplinary research institute devoted to improving the health
of individuals and communities through research innovation. IHBI has
world leading expertise in areas of prostate cancer, infectious
diseases, burns and wound management, genomics, orthopaedics and
trauma, vision, medical robotics and devices and biofabrication.
The Centre for Tropical Crops and Biocommodities, brings together
|Company:||Random42 Scientific Communication|
Random42 is the global leader in providing digital scientific
communication solutions to the pharmaceutical and biotechnology
industry. We bring challenging medical and scientific concepts to
life, making them simple, beautiful and easy to digest.
|• Medical Animation|
|• Scientific Virtual Reality|
|• Augmented Reality|
|• Interactive Touchscreens|
|• Interactive Experiences and Applications|
|• Booth Design and Exhibition Experiences|
|• Web and Print|
With over 27 years’ experience, we have grown into the largest
company within the industry and have won over 175 awards for our
high-quality medical animation and scientific storytelling – a clear
Recro Gainesville provides oral solid dosage form development,
clinical and commercial manufacturing, and packaging services to the
global pharmaceutical market. Specializing in modified release
formulations and DEA controlled substances, Recro has the experts to
deliver clients’ most complex pharmaceutical development and
manufacturing projects in its best-in-class, 120,000 square feet of
manufacturing space. For more information about Recro’s flexible
CDMO solutions, visit www.recrogainesville.com.
Rockville Economic Development, Inc.
Rockville Economic Development, Inc. (REDI) assists businesses
locate and grow in the City of Rockville, Maryland, which is part of
the larger Washington DC Metro area. Rockville offers a family
friendly community, top schools, and lower real estate prices than
many neighboring communities in the Washington DC area. The area is
one of the strongest BioHealth ecosystems in the United States, with
proximity to the National Institutes of Health, Federal Drug
Administration, John Hopkins University and the University of
Maryland. For more information contact us at firstname.lastname@example.org.
|Ticker Symbol & Exchange:||4201, Tokyo Stock Exchange|
BioProduction by Sekisui offers contract development and
manufacturing services for the biopharmaceutical industry. Our
facility in the UK has over 40 years of large scale fermentation and
purification experience. We offer expertise in bioprocess
development, scale up and manufacturing of enzymes, plasmids, and
other proteins for use in the production of biopharmaceuticals. We
offer GLP, ISO 13485 and GMP manufacturing.
|Company:||SINOPEG BIOTECH CO., LTD|
SINOPEG makes high-quality PEG products for therapeutic protein
drugs, medical devices (hydrogel and coatings). Our company serves
pharmaceutical and medical device companies around the globe, with
product presence in various pharmaceutical/device development
pipelines (pre-clinical, clinical, and post authorization large
Our facility is ISO9001 and ISO13485 certified (primarily for GMP
requirement of medical devices), and operates according to ICH GMP
guidelines to produce products for pharmaceutical companies.
Since its inception, SINOPEG has partnered with different stage
pharmaceutical companies and provided pegylation products, PEG
hydrogels, block polymers and liposomes.
|Company:||Site Selection Magazine/Conway Inc.|
For over 65 years Site Selection magazine has been the top-rated and
most respected publication covering foreign direct investment (FDI),
airport cities and global corporate real estate. Site Selection –
winner of the MAGS/GAMMA Gold Award for Best Business to Business
Publication – provides exclusive insight into strategies, real
estate markets, relocation costs and available incentive programs –
in short, the key factors involved in corporate facility planning.
Site Selection’s parent company, Conway Data, offers a host of lead
generation services across the world.
The FDA has advised in its 2014 Guidance for Industry that “It is
Synova is a Full Service Contract Research Organization based out of
Brazil, stemming from the country’s population pool of 200 million.
We are the largest CRO in Latin America, born out of the Brazilian
Bioequivalence Center CAEP, and have become the “Go To” solution in
the Pharma/Biotech and devices Industries.
Thetis is developing a potential first-in-class, safe, oral therapy
for the treatment of inflammatory bowel disease (IBD), a set of
chronic, relapsing gastrointestinal inflammatory disorders that
includes ulcerative colitis and Crohn’s Disease.
|Company:||Two Labs – Pennside Partners|
For over 25 years Two Labs – Pennside Partners has assisted
pharmaceutical companies and investors to identify promising
candidates for in-license/investment. Using this experience, we have
developed a service for emerging biotechnology companies to optimize
positioning and messaging when seeking partnerships and investment.
Pennside Partners uses primary research along with robust
proprietary databases to ensure our clients are up to date on the
current and future treatment landscapes. Utilizing experts such as
former BD&L Managers from Major Pharma/Biotech companies, we provide
best-in-class partnering support for small pharma/biotech and
|Stop by booth 4063 to learn more at BIO 2019.|
|Company:||Validation & Engineering Group|
Validation & Engineering Group (V&EG) provides world-class service
to the Biotechnology, Pharmaceutical, Medical Devices, Chemicals
(API), Food, and Cosmetics industries.
For more than 20 years V&EG has placed talented professionals in a
position to make a difference in our customer’s success. The
technical experience and expertise of our staff, comprised of more
than 140 professionals from the engineering and sciences fields,
keeps us among the top firms in the industries we serve.
Our services platform is split into: Regulatory Compliance,
Validation and Qualification, Laboratory (Validation, Audits), and
Engineering (Design Qualification Services), that ensure adherence
to Federal and European regulatory agencies.
VGXI, Inc. is a leading contract manufacturer of DNA based
pharmaceuticals with over 15 years experience providing exceptional
quality cGMP products to clinical trials worldwide. The company’s
skilled team has an outstanding track record of success in
manufacturing challenging plasmid products under cGMP conditions
with exceptional yield, quality, and prompt delivery. Production
services include high purity plasmid DNA preparations for
pre-clinical research, Highly Documented (HD) plasmid DNA
manufacturing for use in pharmacology / toxicology studies or GMP
viral vector production, and cGMP plasmid DNA for clinical through
Vibalogics is a Contract Development and Manufacturing Organisation
(CDMO) offering process development, cGMP manufacturing and
fill/finish of products based on viruses and live bacteria for
companies developing products used as gene and oncolytic viral
therapies and vaccines. With services including feasibility
assessment, technology transfer, process development, cGMP
manufacturing, formulation/blending, fill/finish (liquid and
lyophilized), QC analysis and Product release, Vibalogics offers a
full range of development and manufacturing services, underpinned by
excellent quality and a transparent customer experience. Established
over fifteen years ago, Vibalogics has a proven track record and is
one of the leading players in live biological manufacturing.
Vistara Bioscience is developing proteomics processes and
bioinformatics for detecting networks of proteins and accessory
factors which are in close collaboration with proteins of clinical
interest. The networks serve as biomarker panels to follow along the
drug discovery process, and additionally, may suggest combinatorial
targets or new ones. Vistara expects to offer Services to pharma and
biotech partners for drug discovery, candidate profiling, and
molecular phenotyping applications with initial focus in Oncology,
Infectious Diseases and CNS disease areas.
We are a multi-disciplinary communications design firm with 25+
years of experience partnering with companies to define their story,
structure their brand, and inspire their audience. We are
media-agnostic and are focused on communicating your company’s story
clearly and effectively across every messaging platform.
For over 25 years we’ve succeeded in helping our clients to grow and
are honored to be a valued partner for some of the most innovative
and successful companies in the world. Our narrative-first approach
unifies corporate, investor and employee communications to build
brand communications systems that are robust for today’s challenges
and extensible for tomorrow’s opportunities.
Strainprint™ Technologies Welcomes Organic Medical Cannabis Producer to Growing List of Subscribers
Strainprint Technologies Ltd, the leader in cannabis data and analytics is pleased to expand their nation-wide coverage with the addition of Stewart Farms.
Stewart Farms is a late-stage applicant headquartered in Alberta that is building a 100,000 sq. ft. vertical aquaponics farm in Saint Stephens, New Brunswick. They will be utilizing automation, vertical farming, and land-based aquaculture to produce medical grade organic cannabis for both recreational and medical markets in Canada. All of their products will be free of herbicides, pesticides and synthetic nutrients. At full capacity, they will reach more than 10,000 kgs per year of organically farmed cannabis and more than 200,000 kgs of organic tilapia.
Stewart Farms’ long term vision is to deliver tools and products to support future customers and patients during their health and wellness journeys. “Through our partnership with Strainprint we gain direct access to their incomparable data and analytics tools. This will aid us in educating a wider audience on the medical benefits and best practices of cannabis-based medicine,” said Tanner Stewart, Co-founder & CEO of Stewart Farms. “We know our customers are looking to consume more than dried cannabis. We know Canadians of all legal ages are trying to sort through their personal engagement with cannabis as a medicine. What we want to know, on an ongoing basis, is what is and is not working for people. Strainprint’s patient-led data services will give us the insight needed to create custom products and further understand the benefits of our existing products. Finally, our goal is to partner with companies and teams that truly have people’s best interest at heart. Caring about a patient’s success is what makes up the core of the Strainprint team. We couldn’t be happier to move forward with them at our side.”
Stewart Farms will access the Strainprint Analytics web platform, the most sophisticated cannabis analytics platform available to improve product development. Strainprint Analytics is built on top of the largest and most granular scientific data set of its kind in the world, with more than 1.3 million anonymized, patient reported medical cannabis outcomes and more than 65 million data points on strain efficacy.
“We’re thrilled to provide our real-time, crowd sourced data to an environmentally conscious company that uses innovative, cutting edge farming technology to produce top-tier medical cannabis,” said Strainprint CEO, Andrew Muroff. “Our organizations are equally committed to improving lives using cannabis therapy, and our shared core motivation is to provide guidance and support to help cannabis patients achieve their health goals.”
SOURCE Strainprint Technologies Ltd.
Field Trip Ventures Inc. Retains KCSA Strategic Communications as Public Relations Counsel
Greenery Map, the world’s first and only cannabis search engine to allow users to search for cannabis products based on their desired mood, medicinal use, and method of consumption, is now offering users – both businesses and consumers – the opportunity to register and connect to the app in an entirely mobile way. Previously, businesses were required to access GreeneryMap.com from a desktop in order to manage accounts and connect to the inventory API system, but that road block has been removed, allowing for an entirely mobile experience through the Greenery Map app.
App users turn to Greenery Map to help them decide on the strain of Cannabis and product that is right for them depending on their desired mood or medicinal effect. Following the matching, consumers are given a detailed history and description of the strain so that they can make educated purchases, cutting down on time that budtenders need to spend with patrons and speeding up the purchase process. Consumers can then see all of the ways to purchase said product, including the nearby dispensaries that have it in stock, online options, and even delivery options through the app. Greenery Map fully integrates with a dispensary’s inventory API system to update in real-time and give consumers real-time information on dispensary stock for the item they are looking for. The Greenery Map system also provides cannabis businesses in both the B2B and B2C sectors a private database to share and sell information and products. For Cannabis businesses, Greenery Map also offers the opportunity to open bank and merchant accounts through their partnership with PayHouse Consulting Group.
SOURCE Greenery Map
WeBank, IBM and Other Organizations Jointly Held the 1st International Workshop on Federated Machine Learning in conjunction with IJCAI 2019
Once a concept, AI is now ushering in a key stage of application. What’s the solution to the data silos among businesses? Given the enhanced regulation on data at home and abroad, what’s the solution to data privacy and security concerns? What’s the status quo of Federated Machine Learning and how to establish an ecosystem for FML in the future?
WeBank, IBM and other organizations jointly held the 1st International Workshop on Federated Machine Learning for User Privacy and Data Confidentiality (FML’19) in conjunction with the 28th International Joint Conference on Artificial Intelligence (IJCAI-19) on Aug. 12, 2019, to further discussion on these issues.
President of IJCAI, Chair of FML Steering Committee, Chief AI Officer of WeBank Professor Qiang Yang delivered opening remarks at the workshop. Dr. Shahrokh Daijavad from IBM and Dr. Jakub Konečný from Google presented keynote addresses. In the panel discussion, top scholars from WeBank, Bar-Ilan University, IBM, Squirrel AI, Google, Huawei, Clustar, Sinovation Ventures and many other renowned enterprises and universities shared and discussed their findings and experience in FML as an emerging AI technology.
This workshop received 40 papers, of which 12 were presented during the workshop, 19 presented via poster. Awards include Best Theory Paper Award, Best Application Paper Award, Best Student Paper Award, Best Presentation Award. Selected high quality papers will be invited for publication in a special issue in the IEEE Intelligent Systems journal. All these attracted numerous scholars to engage in discussions and join efforts for building the FML ecosystem.
Experts from IBM and Google Share Groundbreaking Findings with a Focus on the Theory and Application of FML
Privacy and security are becoming a key concern in our digital age. On 25th May last year, the implementation of General Data Protection Regulation (GDPR) by the EU, the toughest Act on data privacy protection, stressed that user data collection must be open and transparent. A series of laws and regulations from China and overseas also pose new challenges to the traditional way of handling data and model for cooperation. Seeking ways for AI to adapt to this new reality became top priority, a demand that led to this workshop on FML.
A wealth of solutions and breakthroughs were shared by Dr. Shahrokh Daijavad from IBM and Dr. Jakub Konečný from Google in their speech on FML.
Besides how FML can help tackle challenges in the business world, Dr. Shahrokh Daijavad also shared the concept of Fusion AI, which means to train models on widely distributed data sets, but fuse them to produce one equivalent to what centralized training would yield. “Unlike traditional machine learning, in Fusion AI, model parameters are shared and data is not transferred, which makes Fusion AI model better than models that moving data centrally.” Given the widely distributed data, the development of Fusion AI and FML became ever important and imminent.
“FML enables machine learning engineers and data scientists to work productively with decentralized data with privacy by default,” said Dr. Jakub Konečný from Google. He also shared with us how FML works and its use cases at Google. In the case of Gboard, as on-device data is privacy sensitive or large or is more relevant than server-side proxy data, and labels can be inferred naturally via user interaction, the application of Federated RNN compared to prior n-gram model can increase the accuracy of next-word prediction by 24%, and the click rate of prediction strip by 10%.
Major Figure Panelists Discuss the Way Ahead for FML
The moderator of the panel discussion, AI Principal Scientist of WeBank Dr. Lixin Fan joined panelists including Professor Benny Pinkas from Bar-Ilan University, Dr. Shahrokh Daijavad of IBM Academy of Technology, Chief Architect of Squirrel AI Dr. Richard Tong, Research Scientist of Google Dr. Jakub Konečný, Dr. Baofeng Zhang from CTO Office of CBG Software in Huawei, Executive VP of Clustar Dr. Junxue Zhang, VP of AI Institute in Sinovation Ventures Dr. Ji Feng and other experts in a host of in-depth exchanges with attendees, to shed light on the way ahead for FML.
Experts shared thoughts in the panel discussion on questions including but not limited to: How to meet the security and compliance requirements? Is there a way to extend the value of data while observing user privacy and data security? Given the classic trade-off between data regulation and development of AI, how to achieve the long-term goal of establishing a stable and win-win business ecosystem?
List of Award-Winners
Best Theory Paper Award, Best Application Paper Award, Best Student Paper Award and Best Presentation Award selected by all attendees were announced at the closing of the workshop.
Best Theory Paper Award:
Preserving User Privacy for Machine Learning: Local Differential Privacy or Federated Machine Learning? By Huadi Zheng, Haibo Hu & Ziyang Han;
Best Application Paper Award:
FedHealth: A Federated Transfer Learning Framework for Wearable Healthcare. By Yiqiang Chen, Jindong Wang, Chaohui Yu, Wen Gao & Xin Qin;
Best Student Paper Award:
Quantifying the Performance of Federated Transfer Learning. By Qinghe Jing, Weiyan Wang, Junxue Zhang, Han Tian & Kai Chen;
Best Presentation Award:
Federated Generative Privacy. By Aleksei Triastcyn and Boi Faltings.
President of IJCAI, Chief AI Officer of WeBank Professor Qiang Yang, Chief Architect of Squirrel AI Dr. Richard Tong, andVP of AI Institute in Sinovation Ventures Dr. Ji Feng presented the awards.
“The mission of this International Federated Machine Learning Workshop is to facilitate further understanding in the academia, business community as well as legal and regulatory institutions by promoting the establishment of FML ecosystem in the hope that more businesses will join and build a platform for students aspired to work in FML to find research teams that suit them,” said Professor Qiang Yang.
Held Aug. 10-16, 2019 in Macao, China, IJCAI-19 is one of the leading International Academic Conference on AI, attracting over 3000 AI research personnel and experts. The 1st International Workshop on Federated Machine Learning (FML’19) was a highlight for experts joining this event. Visionaries in the academia and industrial sector expressed the willingness to be part of the effort for academic research, application of FML in the future, and the development and boom of AI ecosystem.
Cannabis2 weeks ago
Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update
Cannabis2 weeks ago
MOXIE™ and The Original Jack Herer™ Announce Collaboration
Cannabis2 weeks ago
Fire & Flower Holdings Corp. Opens the Market
Trade Show News2 weeks ago
CyberSecurity – The dangers that lurk in the IoT segment and beyond, Keynote Session with Martin Stoefler (OSM Solutions) at TCE2019 Prague
Cannabis2 weeks ago
Flower One’s Second Quarter Highlighted by Industry Leading Cultivation Performance
Cannabis2 weeks ago
/R E P E A T — SOL Global Announces Proposed Change of Business to U.S. Cannabis MSO, Rebranding to Bluma Wellness Inc./
Cannabis2 weeks ago
Cansortium Announces Opening of its Second Fluent™ Medical Marijuana Dispensary in Puerto Rico
Cannabis2 weeks ago
The Green Organic Dutchman Reports Q2 2019 Results